We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
STAAR Surgical
STAA
$1.26B
| $1.81M | ﹤0.01% |
37,724
+26,052
| +223% | +$1.63M |
|
1302
SandRidge Energy
SD
$525M
| $1.8M | ﹤0.01% |
105,536
-3,763
| -3% | -$70.4K |
|
1303
International Seaways
INSW
$4.53B
| $1.8M | ﹤0.01% |
48,531
+26,959
| +125% | +$1.09M |
|
|
ODP
1304
DELISTED
ODP
ODP
| $1.8M | ﹤0.01% |
39,437
+10,282
| +35% | +$439K |
|
1305
Armstrong World Industries
AWI
$7.74B
| $1.79M | ﹤0.01% |
26,204
+2,328
| +10% | +$176K |
|
1306
Destination XL Group
DXLG
$32.6M
| $1.79M | ﹤0.01% |
264,898
-79,292
| -23% | -$508K |
|
1307
STAG Industrial
STAG
$7.13B
| $1.78M | ﹤0.01% |
55,180
-41,351
| -43% | -$1.3M |
|
1308
HealthStream
HSTM
$828M
| $1.77M | ﹤0.01% |
71,292
+853
| +1% | +$20.5K |
|
1309
Marcus Corp
MCS
$902M
| $1.77M | ﹤0.01% |
122,881
+50,523
| +70% | +$765K |
|
1310
Mercantile Bank Corp
MBWM
$1.06B
| $1.76M | ﹤0.01% |
52,544
+8,724
| +20% | +$292K |
|
1311
Harmony Biosciences
HRMY
$2.3B
| $1.76M | ﹤0.01% |
31,923
-1,453
| -4% | -$79.9K |
|
|
BRT
1312
BRT Apartments
BRT
$265M
| $1.75M | ﹤0.01% |
89,190
+18,106
| +25% | +$372K |
|
1313
VF Corp
VFC
$5.75B
| $1.75M | ﹤0.01% |
+64,176
| New | +$1.89M |
|
1314
New Jersey Resources
NJR
$5.59B
| $1.75M | ﹤0.01% |
35,175
-25,255
| -42% | -$1.15M |
|
1315
National Presto Industries
NPK
$997M
| $1.73M | ﹤0.01% |
25,303
-16,298
| -39% | -$1.11M |
|
1316
Farmers National Banc Corp
FMNB
$953M
| $1.73M | ﹤0.01% |
122,516
+46,517
| +61% | +$657K |
|
1317
Artesian Resources
ARTNA
$364M
| $1.73M | ﹤0.01% |
29,479
+10,864
| +58% | +$572K |
|
|
LYLT
1318
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $1.73M | ﹤0.01% |
817,834
-206,129
| -20% | -$353K |
|
|
PRA
1319
DELISTED
ProAssurance
PRA
| $1.72M | ﹤0.01% |
98,513
+39,921
| +68% | +$787K |
|
1320
RCI Hospitality Holdings
RICK
$207M
| $1.72M | ﹤0.01% |
18,431
-2,326
| -11% | -$194K |
|
1321
Federal Realty Investment Trust
FRT
$10.2B
| $1.72M | ﹤0.01% |
17,024
+4,981
| +41% | +$504K |
|
|
BLD
1322
DELISTED
TopBuild
BLD
| $1.7M | ﹤0.01% |
10,899
-7,607
| -41% | -$1.21M |
|
1323
Ventas
VTR
$45.6B
| $1.7M | ﹤0.01% |
37,806
-1,386
| -4% | -$58.5K |
|
1324
Standard Motor Products
SMP
$882M
| $1.7M | ﹤0.01% |
48,736
-5,099
| -9% | -$187K |
|
|
DNB
1325
DELISTED
Dun & Bradstreet
DNB
| $1.69M | ﹤0.01% |
+138,096
| New | +$1.77M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.